IGALMI is a Sublingual Film in the Human Prescription Drug category. It is labeled and distributed by Bioxcel Therapeutics, Inc.. The primary component is Dexmedetomidine.
Product ID | 81092-1120_2feb689e-7fb4-4865-b6e5-1b5193de2fba |
NDC | 81092-1120 |
Product Type | Human Prescription Drug |
Proprietary Name | IGALMI |
Generic Name | Dexmedetomidine |
Dosage Form | Film |
Route of Administration | SUBLINGUAL |
Marketing Start Date | 2022-07-01 |
Marketing Category | NDA / |
Application Number | NDA215390 |
Labeler Name | BioXcel Therapeutics, Inc. |
Substance Name | DEXMEDETOMIDINE |
Active Ingredient Strength | 120 ug/1 |
Pharm Classes | Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2022-07-01 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
81092-1120 | IGALMI | DEXMEDETOMIDINE |
81092-1180 | IGALMI | DEXMEDETOMIDINE |
16729-239 | Dexmedetomidine | Dexmedetomidine |
16729-432 | DEXMEDETOMIDINE | DEXMEDETOMIDINE |
55150-209 | Dexmedetomidine | Dexmedetomidine |
57884-3091 | DEXMEDETOMIDINE | DEXMEDETOMIDINE |
66794-230 | Dexmedetomidine | Dexmedetomidine |
66794-233 | Dexmedetomidine | Dexmedetomidine |
66794-238 | Dexmedetomidine | Dexmedetomidine |
67457-251 | Dexmedetomidine | dexmedetomidine |
70860-605 | Dexmedetomidine | dexmedetomidine |
71288-505 | DEXMEDETOMIDINE | DEXMEDETOMIDINE |
71872-7150 | Dexmedetomidine | dexmedetomidine |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
IGALMI 98620766 not registered Live/Pending |
BioXcel Therapeutics, Inc. 2024-06-26 |
IGALMI 90295383 not registered Live/Pending |
Bioxcel Therapeutics, Inc. 2020-11-03 |